These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 34766463)
1. The immunomodulatory effect of microglia on ECM neuroinflammation via the PD-1/PD-L1 pathway. Shen Y; Li Y; Zhu Q; Wang J; Huang Y; Liang J; Wu X; Zhao Y CNS Neurosci Ther; 2022 Jan; 28(1):46-63. PubMed ID: 34766463 [TBL] [Abstract][Full Text] [Related]
2. Neurons upregulate PD-L1 via IFN/STAT1/IRF1 to alleviate damage by CD8 Wang Y; Shen Y; Liang J; Wang S; Huang Y; Zhu Q; Zhang X; Yu K; Tong G; Yang C; Li Y; Wang J; Zhao Y J Neuroinflammation; 2024 May; 21(1):119. PubMed ID: 38715061 [TBL] [Abstract][Full Text] [Related]
3. PDL1 Fusion Protein Protects Against Experimental Cerebral Malaria via Repressing Over-Reactive CD8 Wang J; Li Y; Shen Y; Liang J; Li Y; Huang Y; Liu X; Jiang D; Yang S; Zhao Y; Yang K Front Immunol; 2018; 9():3157. PubMed ID: 30693001 [TBL] [Abstract][Full Text] [Related]
4. The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology. Hafalla JC; Claser C; Couper KN; Grau GE; Renia L; de Souza JB; Riley EM PLoS Pathog; 2012 Feb; 8(2):e1002504. PubMed ID: 22319445 [TBL] [Abstract][Full Text] [Related]
5. Expression of negative immune regulatory molecules, pro-inflammatory chemokine and cytokines in immunopathology of ECM developing mice. Khandare AV; Bobade D; Deval M; Patil T; Saha B; Prakash D Acta Trop; 2017 Aug; 172():58-63. PubMed ID: 28454880 [TBL] [Abstract][Full Text] [Related]
6. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA. Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878 [TBL] [Abstract][Full Text] [Related]
8. CD8 Wang J; Zhu Q; Shen Y; Liang J; Wang Y; Huang Y; Tong G; Wang X; Zhang N; Yu K; Li Y; Zhao Y CNS Neurosci Ther; 2024 Mar; 30(3):e14431. PubMed ID: 37697956 [TBL] [Abstract][Full Text] [Related]
9. The T-Cell Inhibitory Molecule Butyrophilin-Like 2 Is Up-regulated in Mild Plasmodium falciparum Infection and Is Protective During Experimental Cerebral Malaria. Subramaniam KS; Spaulding E; Ivan E; Mutimura E; Kim RS; Liu X; Dong C; Feintuch CM; Zhang X; Anastos K; Lauvau G; Daily JP J Infect Dis; 2015 Oct; 212(8):1322-31. PubMed ID: 25883389 [TBL] [Abstract][Full Text] [Related]
10. Transcriptomes of microglia in experimental cerebral malaria in mice in the presence and absence of Type I Interferon signaling. Talavera-López C; Capuccini B; Mitter R; Lin JW; Langhorne J BMC Res Notes; 2018 Dec; 11(1):913. PubMed ID: 30572937 [TBL] [Abstract][Full Text] [Related]
11. Induction of pro-inflammatory mediators in Plasmodium berghei infected BALB/c mice breaks blood-brain-barrier and leads to cerebral malaria in an IL-12 dependent manner. Schmidt KE; Schumak B; Specht S; Dubben B; Limmer A; Hoerauf A Microbes Infect; 2011 Sep; 13(10):828-36. PubMed ID: 21609776 [TBL] [Abstract][Full Text] [Related]
12. Transcriptomic profiling of microglia reveals signatures of cell activation and immune response, during experimental cerebral malaria. Capuccini B; Lin J; Talavera-López C; Khan SM; Sodenkamp J; Spaccapelo R; Langhorne J Sci Rep; 2016 Dec; 6():39258. PubMed ID: 27991544 [TBL] [Abstract][Full Text] [Related]
13. Protein kinase C θ deficiency increases resistance of C57BL/6J mice to Plasmodium berghei infection-induced cerebral malaria. Ohayon A; Golenser J; Sinay R; Tamir A; Altman A; Pollack Y; Isakov N Infect Immun; 2010 Oct; 78(10):4195-205. PubMed ID: 20660606 [TBL] [Abstract][Full Text] [Related]